Therapeutic Evaluation of Unani Coded Drug UNIM-104 in Cases of Non-Alcoholic Fatty Liver Disease (NAFLD) – A Preliminary Clinical Trial
Hafiz C. Mohammad Aslam, Zaheer Ahmed, Shahida Begum, Aijaz Ahmad, K. Kabiruddin, Shaikh Nikhat, Javed Ali, Abdul Kareem and Syed Jameeluddin
Hippocratic Journal of Unani Medicine
Hippocratic Journal of Unani Medicine January - March 2015, Vol. 10 No. 1, Pages 1-7
Fatty liver disease is caused by an accumulation of fat in the hepatocytes. Non Alcoholic Fatty Liver Disease (NAFLD) has been reported worldwide, estimated to be around 10–24% in various populations. There is no standard medical treatment specifically for “Non-alcoholic, non-Diabetic and non- obese Fatty liver Disease”, hence a preliminary clinical study has been conducted at RRIUM Chennai, to evaluate the safety and efficacy of the Unani coded drug UNIM-104 in the treatment of NAFLD. It was observed that there was reduction in the sign and symptoms at the end of trial with statistical improvement (p< 0.05) in Hounz field (HF) Units value on CT scan of liver.